Genetic polymorphisms in Na⁺-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations

References

• Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solís N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ. (2003). Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol 38:148–155.
   PubMedGoogle Scholar
• Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT. (2003). Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE−/− mice by SC-435. J Lipid Res 44:1614–1621.
   PubMed Web of Science ®Google Scholar
• Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. (1998). Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 274:G157–G169.
   PubMed Web of Science ®Google Scholar
• Criado JJ, Domínguez MF, Medarde M, Fernández ER, Macías RI, Marín JJ. (2000). Structural characterization, kinetic studies, and in vitro biological activity of new cis-diamminebis-cholylglycinate(O,O′) Pt(II) and cis-diamminebis-ursodeoxycholate(O,O′) Pt(II) complexes. Bioconjug Chem 11:167–174.
   PubMed Web of Science ®Google Scholar
• Dawson PA, Oelkers P. (1995). Bile acid transporters. Curr Opin Lipidol 6:109–114.
   PubMedGoogle Scholar
• Deng JW, Shon JH, Shin HJ, Park SJ, Yeo CW, Zhou HH, Song IS, Shin JG. (2008). Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm Res 25:1807–1814.
   PubMed Web of Science ®Google Scholar
• Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. (2002). The structure of haplotype blocks in the human genome. Science 296:2225–2229.
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Stieger B, Foguet M, Lübbert H, Meier PJ. (1991). Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci USA 88:10629–10633.
   PubMed Web of Science ®Google Scholar
• Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. (2004). Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem 279:7213–7222.
   PubMed Web of Science ®Google Scholar
• Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. (2006). Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130:1793–1806.
   PubMed Web of Science ®Google Scholar
• Holzer A, Harsch S, Renner O, Strohmeyer A, Schimmel S, Wehkamp J, Fritz P, Stange EF. (2008). Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation. Digestion 78:52–59.
   PubMedGoogle Scholar
• Huff MW, Telford DE, Edwards JY, Burnett JR, Barrett PH, Rapp SR, Napawan N, Keller BT. (2002). Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB. Arterioscler Thromb Vasc Biol 22:1884–1891.
   PubMed Web of Science ®Google Scholar
• Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. (2004). Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53:78–84.
   PubMed Web of Science ®Google Scholar
• Jung D, Fried M, Kullak-Ublick GA. (2002). Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J Biol Chem 277:30559–30566.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Song IS, Shin HJ, Kim WY, Lee CH, Shim JC, Zhou HH, Lee SS, Shin JG. (2007). Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab Dispos 35:667–675.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Maeda K, Wang Y, Sugiyama Y. (2008). Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 36:2014–2023.
   PubMed Web of Science ®Google Scholar
• Love MW, Craddock AL, Angelin B, Brunzell JD, Duane WC, Dawson PA. (2001). Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Thromb Vasc Biol 21:2039–2045.
   PubMedGoogle Scholar
• Mareninova O, Shin JM, Vagin O, Turdikulova S, Hallen S, Sachs G. (2005). Topography of the membrane domain of the liver Na+-dependent bile acid transporter. Biochemistry 44:13702–13712.
   PubMed Web of Science ®Google Scholar
• Oelkers P, Kirby LC, Heubi JE, Dawson PA. (1997). Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 99:1880–1887.
   PubMed Web of Science ®Google Scholar
• Pourmand N, Elahi E, Davis RW, Ronaghi M. (2002). Multiplex pyrosequencing. Nucleic Acids Res 30:e31.
   PubMedGoogle Scholar
• Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG, Costa RH. (2000). Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20:8264–8282.
   PubMedGoogle Scholar
• Renner O, Harsch S, Schaeffeler E, Schwab M, Klass DM, Kratzer W, Stange EF. (2009). Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Hum Genet 125:381–391.
   PubMedGoogle Scholar
• Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, Stoffel M. (2001). Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27:375–382.
   PubMed Web of Science ®Google Scholar
• Sundaram U, Wisel S, Stengelin S, Kramer W, Rajendran V. (1998). Mechanism of inhibition of Na+-bile acid cotransport during chronic ileal inflammation in rabbits. Am J Physiol 275:G1259–G1265.
   Google Scholar
• Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, Trauner M. (2003). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38:717–727.
   PubMed Web of Science ®Google Scholar